Literature DB >> 6202385

Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification.

W B Gill, J L Huffman, E S Lyon, D H Bagley, H W Schoenberg, F H Straus.   

Abstract

Intravesical instillation of methylene blue resulted in selective surface staining of bladder tumors in vivo without staining the background of normal urothelium. Staining of human bladder tumors in vivo was accomplished by the intravesical instillation of 0.1% methylene blue in 0.9% saline through a foley catheter under 20 cm of hydrostatic pressure up to a maximum volume of 400 ml. After 5 minutes contact time, the methylene blue solution was drained, and the bladder was washed with saline. Thereafter, either endoscopic or open surgery was performed. The transitional cell carcinomas in 45 of 48 patients bound methylene blue to the surfaces of the tumors but not to normal urothelium. Higher grade tumors usually bound the dye more extensively than lower grades. The three patients, whose tumors did not bind methylene blue, had received previous chemotherapy, which might account for their being falsely negative. Carcinoma in situ and dysplasia did stain blue. Areas of hyperplasia and cystitis, however, did not bind methylene blue. In vivo intravesical staining with methylene blue has been a simple and safe procedure which has enhanced the endoscopic localization for biopsy and fulguration/resection of transitional cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202385     DOI: 10.1002/1097-0142(19840615)53:12<2724::aid-cncr2820531230>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models.

Authors:  Jesung Park; Pawel Mroz; Michael R Hamblin; Anna N Yaroslavsky
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

2.  The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).

Authors:  F Gaboardi; R Bordinazzo; L Galli
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 3.  Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct.

Authors:  Naveen Chhabra; Shruti Chhabra; Nitin Sapra
Journal:  J Maxillofac Oral Surg       Date:  2014-07-29

4.  P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy.

Authors:  Paulo Anastácio Furtado Pacheco; Leonardo Braga Gomes Ferreira; Leonardo Mendonça; Dinarte Neto M Ferreira; Juliana Pimenta Salles; Robson Xavier Faria; Pedro Celso Nogueira Teixeira; Luiz Anastacio Alves
Journal:  J Bioenerg Biomembr       Date:  2016-07-15       Impact factor: 2.945

Review 5.  Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors:  Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal:  Prog Neurobiol       Date:  2015-11-18       Impact factor: 11.685

6.  Methylene Blue as a Diagnostic Aid in the Early Detection of Potentially Malignant and Malignant Lesions of Oral Mucosa.

Authors:  Abraham Lejoy; Rai Arpita; Burde Krishna; Naikmasur Venkatesh
Journal:  Ethiop J Health Sci       Date:  2016-05

7.  Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral cancerous and precancerous lesions.

Authors:  Manas Gupta; Kriti Shrivastava; Vikalp Raghuvanshi; Sakshi Ojha; Ankita Gupta; S Sasidhar
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

8.  Methylene blue as an early diagnostic marker for oral precancer and cancer.

Authors:  Akhtar Riaz; Balasundari Shreedhar; Mala Kamboj; S Natarajan
Journal:  Springerplus       Date:  2013-03-09

9.  Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level.

Authors:  Anna N Yaroslavsky; Xin Feng; Alona Muzikansky; Michael R Hamblin
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.